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Functional Redundancy of Langerhans Cells and
Langerinþ Dermal Dendritic Cells in Contact
Hypersensitivity
Madelon Noordegraaf1,2, Vincent Flacher3, Patrizia Stoitzner3 and Bjo¨rn E. Clausen1
The relative roles of Langerhans cells (LC), dermal dendritic cells (DC), and, in particular, the recently discovered
Langerinþ dermal DC subset in the induction and control of contact hypersensitivity (CHS) responses remain
controversial. Using an inducible mouse model, in which LC and other Langerinþ DC can be depleted by
injection of diphtheria toxin, we previously reported impaired transport of topically applied antigen to draining
lymph nodes and reduced CHS in the absence of all Langerinþ skin DC. In this study, we demonstrate that mice
with a selective depletion of LC exhibit attenuated CHS only upon sensitization with a low hapten dose but not
with a high hapten dose. In contrast, when painting a higher concentration of hapten onto the skin, which leads
to increased antigen dissemination into the dermis, CHS is still diminished in mice lacking all Langerinþ skin
DC. Taken together, these data suggest that the magnitude of a CHS reaction depends on the number of skin
DC, which have access to the hapten, rather than on the presence or absence of a particular skin DC
population. LC and (Langerinþ ) dermal DC thus seem to have a redundant function in regulating CHS.
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INTRODUCTION
Dendritic cells (DC) are a heterogenous family of antigen-
presenting cells critical for the induction and control of T cell
immunity and tolerance. Upon antigen encounter at epithe-
lial borders to the environment, DC migrate to local lymph
nodes (LN), where they activate naive T cells to become
effector cells (Banchereau and Steinman, 1998; Banchereau
et al., 2000; Steinman et al., 2003). In mouse skin, at least
three phenotypically distinct DC populations can be distin-
guished: Langerhans cells (LC) expressing the C-type lectin
Langerin/CD207 form a contiguous network in the epidermis,
whereas Langerinþ and Langerinneg DC subsets reside in the
dermis (Bursch et al., 2007; Ginhoux et al., 2007; Poulin
et al., 2007). LC can be further separated from Langerinþ
dermal DC by their expression or lack of EpCam and CD103,
respectively (Nagao et al., 2009). Whether the different
skin DC subsets exert specific functions in the regulation of
cutaneous immune responses remains elusive (Romani et al.,
2006, 2010; Clausen and Kel, 2010).
Allergic contact dermatitis (ACD), one of the most
common occupational diseases, leads to considerable
health-related quality of life impairment in affected patients
and its prevention therefore is of high socioeconomic impact.
ACD, also referred to as contact hypersensitivity (CHS), is a
T cell-mediated skin inflammation caused by repeated
exposure to contact allergens, i.e., low-molecular-weight
chemicals called haptens (Vocanson et al., 2009). During the
asymptomatic sensitization phase, haptens penetrating
the skin bind to host proteins, which are then collected
by resident DC that migrate to the LN to activate naive
hapten-specific T cells. In sensitized individuals, re-exposure
to the hapten initiates the effector phase and clinical
expression of ACD, characterized by recruitment and
activation of specific T cells at the site of hapten challenge.
In mice, painting of a sensitizer onto the skin initiates
production of proinflammatory cytokines that activate skin
DC to prime hapten-specific T cells in draining LN (Grabbe
and Schwarz, 1998). Re-exposure to the same hapten onto
the ear induces a transient ear swelling reaction mediated by
IFNg-producing CD8þ T cells and controlled by CD4þ
T cells secreting IL-4 and IL-10 (Gorbachev and Fairchild,
2004). LC have been critically linked to the initiation of
contact sensitivity responses (Toews et al., 1980), however,
recent advances in the pathophysiology of CHS have revi-
sited the dogma that LC are mandatory for T-cell priming.
The essential contribution of LC to hapten sensitization
has recently been challenged in different LC ablation
models (Bennett et al., 2005; Kaplan et al., 2005, 2008;
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Kissenpfennig et al., 2005; Bennett and Clausen, 2007). On
one hand, knock-in mouse strains have been independently
generated by two laboratories, in which expression of the
high-affinity human diphtheria toxin (DT) receptor (DTR) is
driven by the endogenous langerin promotor. In these
Langerin-DTR mice, LC can be depleted for at least 2–4
weeks after a single injection of DT (Bennett et al., 2005).
Initial experiments demonstrated a similar and reduced CHS
responses in the French (Kissenpfennig et al., 2005) and
Dutch (Bennett et al., 2005) Langerin-DTR mice, respec-
tively, as compared with wild type (WT). Later, a population
of Langerinþ dermal DC distinct of epidermal LC was
discovered (Bursch et al., 2007; Ginhoux et al., 2007; Poulin
et al., 2007) and it was established in the French mice that
these recover from the toxin treatment within 1–2 weeks after
DT (Bursch et al., 2007). Using the French Langerin-DTR
mice, it was then shown that CHS responses were indeed
decreased when all Langerinþ skin DC were absent, but
restored to WT levels once the Langerinþ dermal DC subset
had returned (Bursch et al., 2007). In contrast, CHS was still
impaired in the Dutch Langerin-DTR mice 4 weeks after DT
(Bennett et al., 2007).
On the other hand, transgenic mice expressing the toxic
subunit of DT under control of the human langerin promotor
constitutively lack epidermal LC from birth, whereas other
Langerinþ DC populations, in particular, Langerinþ dermal
DC are not affected (Kaplan et al., 2005). These Langerin-
DTA mice mount exaggerated CHS reactions suggesting that
LC play a regulatory rather than a stimulatory role in this
model. Therefore, to date the requirement of LC, Langerinþ
and Langerinneg dermal DC during the sensitization of CHS
remains controversial or unknown.
In this study, we take advantage of the differential
repopulation kinetics between epidermal LC and Langerinþ
dermal DC and assess CHS responses in mice selectively
lacking LC and mice lacking all Langerinþ DC. In particular,
we compare different haptens, hapten concentrations and, for
the first time, the two inducible LC depletion mouse models
side-by-side. Our data demonstrate that in both Langerin-
DTR strains the magnitude of a CHS reaction depends on the
antigen dose and the number of skin DC that have access to
the hapten, rather than the presence or function of one of the
three skin DC subsets.
RESULTS
Rapid steady state repopulation of dermal Langerinþ DC
The skin contains at least three subsets of DC, namely
epidermal LC and Langerinþ and Langerinneg dermal DC. In
Langerin-DTR mice, all Langerinþ cells are rapidly depleted
upon injection with DT. We previously described that steady
state LC reconstitution of the epidermis takes at least 2–4
weeks (Bennett et al., 2005), whereas Langerinþ LN DC
recover faster from the toxin treatment (Bennett et al., 2007).
These data were obtained before the recent discovery of a
distinct subset of Langerinþ DC in the dermis, and in this
study we further characterize the steady state repopulation of
dermal Langerinþ cells. Langerin-DTR mice were injected
with DT and the repopulation kinetics of Langerinþ cells in
epidermis, dermis, and LN was assessed (Figure 1). As
expected, 2 days after toxin treatment all Langerinþ DC in
epidermis, dermis, and LN were efficiently depleted. Already
after 1 week, Langerinþ cells were reappearing in the
dermis and in skin-draining LN, and continued to increase
in numbers over time, whereas the epidermis essentially
remained devoid of LC. Nonetheless, we observe only a
partial recovery of the Langerinþ CD103þ DC population in
the dermis and skin-draining LN (Figure 1b). In fact, the rare
Langerinþ major histocompatibility complex IIþ (MHCIIþ )
DC present in the dermis 2 weeks after DT are difficult to
make out in cross-sections of ear skin (Figure 1a, right panel,
white arrowhead). Analysis of Langerinþ cells among whole
ear skin crawl-outs analyzed 15 days after DT confirms the
profound LC deficiency and incomplete reconstitution of
Langerinþ CD103þ dermal DC (Figure 1c). Notably, the
French and Dutch Langerin-DTR mice show a similar
Langerinþ dermal DC recovery of 44.7 and 29.2%,
respectively (calculated from absolute numbers of migratory
cells, Figure 1c). Consequently, topical application of FITC 2
or 10 days after DT results in antigen transport to draining
LN by Langerinneg dermal DC or both Langerinþ and
Langerinneg dermal DC subsets (Supplementary Figure S1
online). This difference in repopulation kinetics between LC
and Langerinþ dermal DC after toxin treatment enables us to
study CHS responses in the absence of all Langerinþ cells or
in the absence of LC alone (see Table 1 for an overview).
Low-dose CHS is decreased in the absence of both all
Langerinþ DC and LC alone
We have previously shown that in the absence of all
Langerinþ cells CHS responses are diminished due to
inefficient hapten transport to local LN for the priming of
naive antigen-specific T cells (Bennett et al., 2005, 2007). In
this study, we investigated the differential roles (if any) of
epidermal LC versus Langerinþ and Langerinneg dermal DC
in mediating CHS. Taking advantage of the slow return of the
epidermal LC in relation to dermal Langerinþ DC, we
injected mice with DT 2 days before inducing CHS to deplete
all Langerinþ cells, or 10 days before inducing CHS to
selectively deplete epidermal LC only (Table 1). On the basis
of our observation that a reduced dose of hapten preferen-
tially targets LC in the epidermis (Bennett et al., 2007), we
sensitized mice with 0.5% oxazalone on the shaved abdo-
men and challenged with 0.25% of oxazalone on one ear 5
days later. Consistent with our previous findings, CHS
responses are significantly reduced in Langerin-DTR mice,
when they lack all Langerinþ cells. Similarly, mice in which
dermal Langerinþ cells have recovered from the toxin,
exhibit a diminished CHS response at this low oxazolone
concentration as compared with WT (Figure 2a).
To exclude any bias of a particular hapten (oxazolone) on
the results of this study, we also induced low-dose CHS with
2,4-dinitrofluorobenzene (DNFB). As depicted in Figure 2b,
upon sensitization with 0.5% followed by challenge with
0.25% DNFB, CHS responses are significantly impaired 2
days as well as 10 days after injection of DT. These data
indicate that at low-hapten concentrations, CHS is reduced
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both in the absence of all Langerinþ DC and of LC alone,
irrespective of the type of hapten.
High-dose CHS is only diminished in mice lacking all
Langerinþ DC
To address the contribution of Langerinþ dermal DC to CHS
reactions, we painted a higher concentration of hapten onto
the skin leading to increased antigen dissemination into
the dermis. We sensitized and challenged the mice with 2
and 0.5% oxazolone or 1 and 0.5% DNFB, respectively.
As expected, mice lacking all Langerinþ cells still develop
significantly diminished CHS to both haptens (Figure 3a and
b, left panels). In contrast, when only epidermal LC are
absent, CHS responses are comparable with WT mice, and
when they are reduced, this difference often is not significant
(Figure 3, right panels). These findings suggest that once a
hapten efficiently reaches the dermis, LC are dispensable
and (Langerinþ ) dermal DC are sufficient for the induction of
an effective CHS response.
Similar reduction of low- and high-dose CHS in French and
Dutch Langerin-DTR mice
Performing similarly timed DT treatments, using the French
Langerin-DTR mice, Bursch et al. (2007) reported diminished
Table 1. Low- and high-dose CHS in the presence or
absence of distinct skin DC subsets
Composition of skin DC
compartment
Low-dose
CHS
High-dose
CHS
WT ++ +++
Lack of epidermal LC only
(DT day 10 or 15)
k Similar (++)
Lack of all Langerin+ cells
(DT day 1 or 2)
k k
Abbreviations: CHS, contact hypersensitivity; DC, dendritic cell; DT,
diphtheria toxin; LC, Langerhans cells; WT, wild type.
+ Degree of ear swelling; k reduction in ear swelling as compared with
WT mice.
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Figure 1. Steady state repopulation of Langerinþ dendritic cell (DC) populations. (a) Anti-Langerin (red fluorescence) and anti-major histocompatibility
complex II (MHCII) (green fluorescence) staining of ear cross-sections of wild type (WT) (left panel) and Langerin-diphtheria toxin receptor (DTR) mice (‘‘Dutch
mice’’) injected with diphtheria toxin (DT) at 48 hours (middle panel) or 14 days (right panel) earlier. The arrowhead identifies one of the rare Langerinþ dermal
DC (yellow fluorescence) that had recovered from the toxin at 2 weeks. Bars ¼ 50 mm. (b) Recovery of Langerinþ cells in epidermis, dermis, and cutaneous
lymph node (LN). Mice were injected with DT at day 0. Single-cell suspensions were prepared at different time points and analyzed for the presence of
Langerinþ cells. Values of untreated mice (day 0) were set equal to 100%. The graph shows the percentages of MHCIIþ Langerinþ cells (mean±SD). In dermal
suspensions, epidermal Langerhans cells (LC) in transit and Langerinþ dermal DC were distinguished by differential expression of EpCam and CD103 (not
shown). Only numbers of CD103þEpCamneg dermal Langerinþ cells are considered in the columns for dermis. Four mice per time point were analyzed. (c) At
15 days after injection of phosphate-buffered saline (PBS) or DT, whole-skin explants were prepared from the ears of French or Dutch Langerin-DTR mice, and
further cultured for 4 days. Migratory cells from 4–6 skin explants were pooled and stained for CD11c, Langerin and CD103. At least 3,000 live migratory cells
were acquired by fluorescence activated cell sorting. Dot plots display migratory cells gated for Langerin expression. Percentages represent the proportions of
CD11cþ CD103neg LC and CD11cþ CD103þ Langerinþ dermal DC. Results are representative of two independent experiments.
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CHS in the absence of all Langerinþ DC, but no reduction in
CHS when only LC are absent from the skin. Therefore, it was
important to compare low- and high-dose CHS responses in
the French and Dutch Langerin-DTR mice immediately or 10
days after DT. As shown in Figure 4, following a low-dose
protocol of inducing CHS to oxazolone both Langerin-DTR
mice mount attenuated ear swelling reactions in the absence
of all Langerinþ DC (Figure 4a) and LC alone (Figure 4b).
These results demonstrate that when tested in the same
experiment, under conditions that limit hapten delivery prefere-
ntially to the epidermis, the French and Dutch Langerin-DTR
mice develop equally reduced CHS after ablation of all
Langerinþ DC, but also in the selective absence of LC. In
addition, when analyzed side-by-side both Langerin-DTR
mutants respond similarly in high-dose CHS (Figure 5).
DISCUSSION
CHS, in the form of occupational ACD to low-molecular-
weight chemicals (haptens), leads to a considerable impair-
ment of the quality of life in affected patients (Vocanson
et al., 2009). Initiation of disease is critically linked to the
migration of skin DC to local LN and activation of naive
hapten-specific T cells during the asymptomatic sensitization
phase. Re-exposure to the relevant hapten induces the
effector phase and clinical expression of ACD. DC are a
heterogenous family of antigen-presenting cells and as such key
regulators of T cell immunity and tolerance (Banchereau and
Steinman, 1998; Banchereau et al., 2000; Steinman et al.,
2003; Steinman and Banchereau, 2007). Therefore, a better
understanding of DC function in CHS may open improved
immunotherapeutic approaches to treat patients with ACD.
The skin contains at least three phenotypically
distinct DC populations (Merad et al., 2008). A network of
Langerinþ EpCamþ CD103neg LC is located in the epi-
dermis and Langerinþ EpCamneg CD103þ and Langerinneg
prototypic tissue DC reside in the dermis (Nagao et al., 2009).
All three skin DC subsets can migrate to draining LN in
response to local inflammation, but whether they have
specific roles in inducing or regulating an immune response
is still largely unknown. LC have long been considered
mandatory for CD8þ T-cell priming in CHS, however, this
paradigm has recently been challenged in experiments using
different LC-deficient mouse models (Bennett and Clausen,
2007; Kaplan et al., 2008).
To date, two types of LC ablation models have been
generated and analyzed in CHS. On one hand, LC-deficient
Langerin-DTA transgenic mice, which constitutively lack LC
from birth, whereas other Langerin-expressing DC popula-
tions, in particular, Langerinþ dermal DC are not affected
(Kaplan et al., 2005). On the other hand, two Langerin-DTR
knock-in strains, which enable the inducible depletion of
LC and other Langerinþ DC by the injection of DT
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Figure 2. Contact hypersensitivity reactions to low-dose hapten. Wild type (WT) or Langerin-diphtheria toxin receptor (DTR) mice (‘‘Dutch mice’’) injected
with diphtheria toxin (DT) at day 2 or 10 (n¼ 6–8) were (a) sensitized on the abdomen with 0.5% oxazolone and challenged 5 days later with 0.25%
oxazolone on one ear, or (b) sensitized with 0.5% 2,4-dinitrofluorobenzene (DNFB) and challenged with 0.25% DNFB. Ear swelling was measured as the
difference between before and after challenge. One representative experiment out of three is shown; symbols represent individual mice. Ear swelling
responses were compared using a Student’s t-test; WT versus DTR þ DT: *Pp0.05. LC, Langerhans cells.
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(Bennett et al., 2005; Kissenpfennig et al., 2005). Against
common expectation from the ‘LC paradigm’ (Wilson and
Villadangos, 2004), CHS reactions were not abolished in any
of these LC ablation models indicating that dermal DC can
contribute to the priming of hapten-specific CD8þ T cells in
CHS (Bennett and Clausen, 2007; Kaplan et al., 2008).
The reasons why Langerin-DTA mice show enhanced CHS
are not clear. It has been interpreted to suggest that LC may
have a regulatory function in vivo (Kaplan et al., 2005).
Alternatively, one may speculate that exaggerated T cell
immunity in Langerin-DTA mice results from the constitutive
LC deficiency and failing peripheral tolerance mechanisms
during development of the immune system. Therefore,
whether or not LC are, e.g., required for efficient skin graft
rejection remains controversial (Merad et al., 2004; Obhrai
et al., 2008).
By injecting DT after sensitization, but before hapten
challenge into the two inducible LC depletion models, it was
consistently found that LC (and Langerinþ dermal DC)
have no role in regulating the effector T cell response in
CHS. In contrast, when DT was given during or shortly before
sensitization CHS reactions were reported to be similar
(Kissenpfennig et al., 2005) or diminished (Bennett et al.,
2005) as compared with WT. In 2007, it was discovered that
not all Langerinþ cells in the dermis were transmigrating LC,
but that a second phenotypically distinct Langerinþ DC
subset was located in the dermis (Bursch et al., 2007;
Ginhoux et al., 2007; Poulin et al., 2007). Thus, the initial
CHS experiments in Langerin-DTR mice were in fact
performed in the absence of both Langerinþ skin DC subsets.
After it was described in the French mice that the dermal
Langerinþ DC recover faster from the toxin treatment than
the LC, these discordant CHS results were reconciled by
documenting reduced CHS in the absence of all Langerinþ
skin DC, whereas CHS was indistinguishable from WT when
only LC were absent (Bursch et al., 2007). From this it was
proposed that dermal Langerinþ DC, but not LC, are critical
to mediate CHS.
In this study, we establish that also in the Dutch Langerin-
DTR mice a fraction of dermal Langerinþ DC has returned
already 2 weeks after DT, when the epidermis is still devoid
of LC. This confirms earlier observations (Nagao et al., 2009)
and is in line with the repopulation kinetics of DC depleted
from CD11c-DTR mice, which fully recover to pre-DT levels
within 1 week (Jung et al., 2002). Although it is not clear why
in the skin there is only partial (o50%) reconstitution of LC and
Langerinþ dermal DC in the steady state (Figure 1b and
(Bennett et al., 2005; Bursch et al., 2007)), the two inducible
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Figure 3. Contact hypersensitivity responses elicited by high-dose hapten. Wild type (WT) or Langerin-diphtheria toxin receptor (DTR) mice (‘‘Dutch mice’’)
injected with diphtheria toxin (DT) at day 2 or 10 (n¼ 6–8) were (a) sensitized on the abdomen with 2% oxazolone and challenged 5 days later with 0.5%
oxazolone on one ear, or (b) sensitized with 1% 2,4-dinitrofluorobenzene (DNFB) and challenged with 0.5% DNFB on one ear. Ear swelling was measured as
the difference between before and after challenge. One representative experiment out of three is shown; symbols represent individual mice. Ear swelling
responses were compared using a Student’s t-test; WT versus DTRþDT: *Pp0.05. LC, Langerhans cells.
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Langerin-DTR models show similar depletion and repopulation
dynamics of Langerinþ (skin) DC populations (Figure 1c).
During our earlier experiments, we observed that differ-
ences in ear swelling between DT-treated and -untreated
mice were less significant at standard concentrations as
compared with low concentrations of hapten, e.g., trinitro-
chlorobenzene (Bennett et al., 2005) and oxazolone (Bennett
et al., 2007) and proposed that LC are mainly required for
efficient induction of CHS when antigen dissemination into
the dermis is limited. This observation was anticipated by
Bacci et al. (1997), who also suggested that the requirement
for LC in CHS was only given at low doses of hapten. In
elegant syngeneic grafting experiments, the authors demon-
strate that epidermal grafts obtained from ear skin treated
with DNFB at a low dose sensitized the recipient mice. In
contrast, dermal grafts failed to induce CHS when the donor
skin received an epicutaneous application of a low dose of
DNFB, whereas vigorous CHS was detected by dermal grafts
prepared from skin treated with a high dose of DNFB. This
hypothesis of antigen diffusion/access is in agreement with
the requirement of LC for effective tumor immunotherapy
after epicutaneous immunization with low dose of antigen
(Stoitzner et al., 2008), however, our previous studies were
carried out before the Langerinþ dermal DC were described.
To determine whether the magnitude of a CHS reaction is a
function of antigen dose or the presence of Langerinþ dermal
DC, we assessed both low- and high-hapten dose CHS in
mice lacking all Langerinþ DC or selectively depleted of
epidermal LC (Figures 2 and 3). Consistent with our previous
data and with Bursch et al. (2007), CHS responses are
attenuated in the absence of all Langerinþ cells applying
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Figure 4. Comparison of low-dose contact hypersensitivity in French and
Dutch Langerin-diphtheria toxin receptor (DTR) mice. Wild type (WT),
French or Dutch Langerin-DTR mice injected with diphtheria toxin (DT) at
(a) day 1 or (b) day 10 (n¼ 6–9) were sensitized on the abdomen with
0.5% oxazolone and challenged 5 days later with 0.25% oxazolone on one
ear. Swelling was measured as the difference between challenged (right) and
unchallenged (left) ear. The summary of 2–3 experiments is shown; symbols
represent individual mice. Ear swelling responses were compared using a
Student’s t-test; WT versus DTRþDT: *Pp0.05. LC, Langerhans cells.
0.0
0.1
0.2
24 hours 48 hours
Ea
r s
w
el
lin
g 
(m
m)
Ea
r s
w
el
lin
g 
(m
m)
10 Days post DT
Lack of epidermal LC only
1 Day post DT
Lack of all Langerin+ cells
*
*
*
*
*
*
*
0.00
0.05
0.10
0.15
WT French
DTR + DT
Dutch
DTR + DT
WT French
DTR + DT
Dutch
DTR + DT
24 hours 48 hours
WT French
DTR + DT
Dutch
DTR + DT
WT French
DTR + DT
Dutch
DTR + DT
Figure 5. High-dose contact hypersensitivity in French and Dutch
Langerin-diphtheria toxin receptor (DTR) mice. Wild type (WT), French or
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both a low and a higher dose of oxazolone or DNFB onto the
skin. In contrast, when only epidermal LC are absent CHS is
still diminished at a low-hapten dose, but restored to WT at a
higher concentration of both oxazolone and DNFB (summar-
ized in Table 1). Notably, low-dose CHS is similarly reduced
in DT-treated French Langerin-DTR mice irrespective of the
presence or absence of Langerinþ dermal DC (Figure 4).
Furthermore, both Langerin-DTR models equally respond in
high-dose CHS (Figure 5), which excludes any ambiguity
concerning the different Langerin-DTR strains.
While this paper was under revision, a study by Honda
et al. (2010) using the French Langerin-DTR model reported
reduced CHS to DNFB in the absence of all Langerinþ skin
DC, whereas CHS was similar to WT in mice lacking either
LC or Langerinþ dermal DC. In agreement with the present
study, this suggests that both Langerinþ skin DC subsets play
compensatory roles in the sensitization phase of CHS.
However, it remains elusive why the authors fail to detect
the essential role of LC for efficient sensitization at a low
antigen dose as described in this study and observed by
others (Bacci et al., 1997 and Stoitzner et al., 2008). Since we
have assessed the same antigen (DNFB), depletion timing (DT
day 1 and day 10) and LC ablation model (French
Langerin-DTR mice) as used by Honda et al., a difference in
antigen concentration seems to be the only remaining
explanation for this discordant observation.
Taken together, we demonstrated that the population
dynamics of, in particular, Langerinþ dermal DC is similar in
the Dutch and French Langerin-DTR mice and that both
strains mount comparable CHS responses when tested side-
by-side. These data strongly suggest that the magnitude
of a CHS reaction depends on the concentration of a given
hapten and the number of DC present in the skin, which
activate naive hapten-specific T cells in the LN. This confirms
and extends classical observations on the role of LC in
CHS (Toews et al., 1980; Bacci et al., 1997). In particular, the
degree of CHS is not dependent on a specific skin DC subset,
i.e., Langerinþ dermal DC. Therefore, LC and (Langerinþ )
dermal DC exert redundant functions in mediating CHS.
MATERIALS AND METHODS
Mice
WT C57Bl/6 mice were obtained from Harlan. Generation of the
Dutch Langerin-DTR knock-in mice expressing the high-affinity
human DTR has been described previously (Bennett et al., 2005).
Mice were housed in the animal facilities of the Academic Medical
Center (Animal Research Institute Amsterdam, University of Am-
sterdam) or Innsbruck Medical University, except for the French
Langerin-DTR mice (Kissenpfennig et al., 2005), which were only
kept in Innsbruck. All animal experimentation was in compliance
with EU as well as national laws and approved by the local ethical
committees.
Toxin treatment
As reported previously, mice were intraperitoneally injected with
400 ng DT (Sigma-Aldrich, Zwijndrecht, the Netherlands) in
phosphate-buffered saline (Bennett et al., 2005). For the inducible
depletion of all Langerinþ DC, mice were treated with DT 2 days
prior to induction of CHS. To specifically deplete epidermal LC,
mice were injected 14 days before hapten sensitization.
FITC painting
FITC (Sigma-Aldrich) was dissolved in DMSO and diluted to 1% in
1/1 acetone/dibutylphthalate (Sigma-Aldrich). A volume of 25 ml
was painted on the dorsal side of both ears. After 48 hours, draining
LN were collected and DC were isolated and analyzed by flow
cytometry.
Induction of CHS
To elicit CHS, WT and DT-treated Langerin-DTR mice were
sensitized with 50 ml of either 0.5 or 2% oxazolone (Sigma) in
acetone:olive oil (4:1) on the shaved abdominal skin. Five days later,
mice were challenged with 20ml of 0.25 or 0.5% oxazolone on the
right ear. Ear swelling was measured at 24 and 48 hours post
challenge. CHS responses were calculated as the difference between
ear thickness before and after challenge. Alternatively, mice were
sensitized with 50 ml of either 0.5 or 1% DNFB (Sigma-Aldrich) on
day 0 and challenged with 20 ml of 0.25 or 0.5% DNFB on the right
ear 5 days later. In the experiments depicted in Figures 4 and 5, the
mice were sensitized with 50 ml of 0.5% or 2% oxazolone and
challenged with 20 ml of 0.25% or 0.5% oxazolone on both sides of
one ear. Swelling was measured as the difference of challenged
(right) and unchallenged (left) ear.
Isolation of DC
Epidermal and dermal cells were prepared from the ears of C57BL/6
and DT-treated Langerin-DTR mice. Dorsal and ventral sides of ears
were floated on a solution of 1.2Uml1 dispase (Roche Applied
Bioscience, Almere, the Netherlands) in RPMI for 90minutes at
37 1C, in order to separate dermis and epidermis. Next, the
epidermis was incubated in 0.5% trypsin in RPMI and the dermis
in 500Uml1 collagenase D (Worthington Biochemicals, Lake-
wood, NJ) in RPMI for 45minutes at 37 1C. Epidermis and dermis
were then mechanically scraped and passed through a 70 mm filter
before the cells were washed and resuspended in fluorescence
activated cell sorting buffer. Skin-draining LN were harvested and
incubated with collagenase D (Worthington Biochemicals) and
EDTA to facilitate release of DC.
Whole-skin explant culture
Briefly, ears of mice previously treated with phosphate-buffered
saline or DT were cut off at the base, and ear skin was split into
dorsal and ventral halves (Stoitzner et al., 2003). The dorsal halves
were cultured in 24-well plates (one per well) in complete culture
medium, without additional chemokines. After 4 days, emigrant DC
were pooled from four to six individual ear skin explants, and
investigated by flow cytometry.
Flow cytometry
For flow cytometric analysis, cells were incubated with Fc Block
(2.4G2, BD Pharmingen, Rotterdam, the Netherlands) and stained
with anti-CD11c-PE, (N418, eBioscience, Frankfurt, Germany),
anti-MHCII-PE (M5/114, BD Pharmingen), anti-EpCam-PerCp-Cy5.5
(G8.8, Biolegend, Uithoorn, the Netherlands) and anti-CD103-
Alexa647 (2E7, Biolegend). For intracellular staining with anti-
Langerin-Alexa488 or anti-Langerin-biotin (929.F3, Dendritics,
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Lyon, France), cells were fixed in 2% paraformaldehyde and stained
in 0.5% saponin buffer. PE-Cy7-conjugated streptavidin (BD
Pharmingen) was used to visualize biotin-conjugated antibody.
Experiments were performed on a FACSCanto and analyzed using
FlowJo software (Becton Dickinson, Breda, the Netherlands).
Immunofluorescence on ear cryosections
Cross-sections from ears were fixed in acetone and stained according
to standard procedures with anti-Langerin (929.F3, Dendritics)
followed by anti-rat-Cy3 (Jackson Immunoresearch Laboratories,
Suffolk, UK) and anti-MHCII-Alexa488 (M5/114, BD Pharmingen).
Images were viewed using a DMRA fluorescence microscope (Leica,
Rijswijk, the Netherlands). Pictures were taken with a Kx14 camera
(Apogee Instruments, Roseville, CA).
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